L40.0
Conditions
Interventions
Group 1: Patients with plaque psoriasis who initiate systemic therapy will complete various questionnaires before the start and after 16 and 28 weeks of therapy. In addition, a psychological diagnosti
Sponsors
Universitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Patients suffering from plaque psoriasis with an indication for systemic treatment
Exclusion criteria
Exclusion criteria: • Pregnant or breast-feeding women or lack of willingness to use effective contraception • Insufficient communication skills in the German language, dementia or functional analphabetism • Lack of capacity or will to consent to the study • Existing contraindication to anti-psoriatic systemic treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Affect / depressive symptomatology after 16 and 28 weeks of treatment, assessed using the MADRS interview and BDI-II and STADI questionnaires | — |
Secondary
| Measure | Time frame |
|---|---|
| • Patients' body image after 16 and 28 weeks of treatment assessed using FKB-20 and CBIS questionnaires, diagnostic interview and a subjective measure of affected body surface | — |
Countries
Germany
Contacts
Public ContactStefanie Hölsken
Universitätsklinikum Essen (AöR), Institut für Didaktik in der Medizin
Outcome results
None listed